Recently, the recommendations for the treatment of Clostridioides difficile infection (CDI)
have been updated. However, in addition to the clinical efficacy data, the drug of choice …

The infection caused by Clostridioides difficile represents one of the bacterial infections with
the greatest increase in incidence among nosocomial infections in recent years. C. difficile is …

Clostridioides difficile infection (CDI) in clinical practice represents a challenge for its
management and also prevention of recurrence. Even though there are updated guidelines …

With current first-in-line antibiotic therapy options associated with high levels of recurrent
CDI, the availability of new generation targeted therapeutics can really impact treatment …

Purpose We aimed to evaluate the efficacy of different antibiotic regimens for the treatment
of Clostridioides difficile infection (CDI) with regard to the CDI episode number and disease …

Clostridioides difficile (C. difficile) is a gram-positive, anaerobic spore-forming bacterium and
a major cause of antibiotic-associated diarrhea. Humans are naturally resistant to C. difficile …

Clostridioides difficile infection (CDI) is a common cause of diarrhea in both inpatient and
outpatient settings. The last few years have seen major changes in the treatment spectrum of …

Objectives Clostridioides difficile infection (CDI) is one of the leading nosocomial infections
worldwide, resulting in a significantly increasing burden on the healthcare systems …

Abstract Purpose of Review Clostridioides difficile infection (CDI) represents a major burden
on the US healthcare system. Despite the US Food and Drug Administration (FDA) approval …

Guidelines for the diagnosis and treatment of Clostridioides difficile infection have recently
been updated. Risk factors include recent exposure to health care facilities or antibiotics …